Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
MYC and Breast Cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. N Engl J Med. 2016 Aug 25; 375(8):740-53.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Female
Humans
Intention to Treat Analysis
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Remission Induction
Sialic Acid Binding Ig-like Lectin 2
Survival Analysis
Young Adult
authors with profiles
Wendy Stock